Earlier HRT May Pose Lower CHD Risk for Menopausal Women

Share this content:
Earlier HRT May Pose Lower CHD Risk for Menopausal Women
Earlier HRT May Pose Lower CHD Risk for Menopausal Women

THURSDAY, Oct. 1, 2015 (HealthDay News) -- Women who start hormone therapy toward the beginning of menopause may have a lower risk of developing coronary heart disease, new research suggests. The findings were presented at the annual meeting of the North American Menopause Society, held from Sept. 30 to Oct. 3 in Las Vegas.

Researchers led by German Carrasquilla, M.D., of the Karolinska Institute in Stockholm, combined the results of five Swedish studies. The studies began between 1991 and 2006. They had information on 74,352 women who were followed for up to 23 years.

During that period, 4,714 women developed or died from coronary heart disease. But compared with women who'd never used hormone therapy, those who'd begun it within five years of their first menopause symptoms remained free of coronary heart disease longer -- 1.3 years, on average. That advantage was seen even when the researchers accounted for other major factors such as age, education level, smoking habits, weight, and hypertension.

Carrasquilla told HealthDay that animal research has shown that early hormone therapy helps prevent the buildup of plaques, while delayed therapy does not.

Abstract No. S-17
More Information

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease


More in Home

CDC: Too Many Health Care Workers Not Getting Flu Vaccine

CDC: Too Many Health Care Workers Not Getting ...

Vaccination protects both workers and patients

Early Mobilization Improves Outcomes, LOS in Surgical ICUs

Early Mobilization Improves Outcomes, LOS in Surgical ICUs

Patients discharged sooner, become more functional when they leave the hospital

is free, fast, and customized just for you!

Already a member?

Sign In Now »